Keyphrases
Physical Performance
100%
Branched-chain Amino Acids
100%
Collagen Synthesis
100%
End-stage Liver Disease
100%
Hepatic Stellate Cell Activation
100%
Arginase-1 (Arg-1)
100%
Diseases Therapeutic
100%
Disease Mechanisms
100%
Therapeutic Implications
100%
Extracellular Vesicles
100%
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Disease Diagnosis
100%
Prognostic Implications
100%
Inducible Nitric Oxide Synthase
66%
Amino Acid Content
37%
Arginine
33%
Timed Up-and-go Test
25%
Muscle Function
25%
Liver Disease Severity
25%
Macrophage Polarization
22%
Extracellular Matrix
22%
Proline
22%
Collagen
22%
Cargo
22%
Marker-and-cell
14%
Hepatic Encephalopathy
12%
Balance Test
12%
Sit-to-stand
12%
Liver Transplantation
12%
Clinical Frailty Scale
12%
NMR Spectroscopy
12%
Child-Pugh
12%
Standing Balance
12%
January 2017
12%
Handgrip Strength Test
12%
Sit-to-stand Test
12%
Walk Test
12%
Poor Prognosis
12%
Sarcopenia
12%
Prognostic Marker
12%
Sex-stratified
12%
Amino Acid Profile
12%
Arginine Catabolism
11%
Pro-fibrogenic
11%
Liver Fibrogenesis
11%
Amino Acids
11%
Cirrhosis
11%
Expression Profile
11%
Catabolic Enzymes
11%
Inflammatory Markers
11%
Medicine and Dentistry
Physical Performance
100%
Hepatic Stellate Cell
100%
Branched Chain Amino Acid
100%
Cell Activation
100%
End Stage Liver Disease
100%
Collagen Synthesis
100%
Arginase 1
100%
Diagnosis
100%
Non-Alcoholic Fatty Liver Disease
100%
Liver Disease
45%
Arginine
44%
Liver Cirrhosis
31%
Fibrosis
31%
Timed Up and Go Test
25%
Muscle Function
25%
Amino Acid
23%
Arginase
22%
Macrophage Polarization
22%
Proline
22%
Nitric Oxide Synthase
22%
Extracellular Matrix
22%
Homeostasis
20%
Prevalence
20%
Cell Communication
20%
Disease
20%
Nonalcoholic Fatty Liver
20%
Biological Marker
20%
Therapeutic Agent
20%
Target Cell
20%
Hand Grip
12%
Liver Graft
12%
Nuclear Magnetic Resonance Spectroscopy
12%
Disease Severity
12%
Sarcopenia
12%
Walk Test
12%
Frailty
12%
Hepatic Encephalopathy
12%
Cell Proliferation
11%
Biosynthesis
11%
Precursor
11%
Liver Fibrosis
11%
Fibrogenesis
11%
Neuronal Nitric Oxide Synthase
11%
Pharmacology, Toxicology and Pharmaceutical Science
Arginase 1
100%
Fatty Liver
100%
Branched Chain Amino Acid
100%
Oxoacid
66%
End Stage Liver Disease
66%
Arginine
44%
Prevalence
36%
Isoleucine
33%
Leucine
33%
Liver Cirrhosis
31%
Fibrosis
31%
Liver Fibrosis
27%
Amino Acid
27%
Proline
22%
Nitric Oxide Synthase
22%
Arginase
22%
Biological Marker
20%
Disease
20%
Nonalcoholic Fatty Liver
20%
Liver Disease
20%
Rat Model
16%
Liver Injury
16%
2 Oxoisovalerate Dehydrogenase (Lipoamide)
16%
Valine
16%
Neuronal Nitric Oxide Synthase
11%
